Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorTimothy Mullett

About this trial

This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Member of a participating Lung Cancer Screening Program (LCSP) team or administrator

Willing to participate in the QUILS Index Assessment Survey process

Willing to participate in the QUILS Audit Feedback presentations

Willing to participate in formative evaluation interviews

Disqualifiers

Unwilling to participate in the QUILS Index Assessment Survey process

Unwilling to participate in the QUILS Audit Feedback presentations

Unwilling to participate in formative evaluation interviews

Trial design

Design model

Single group

Treatments tested in this trial

  • Quality Implementation of Lung Cancer Screening (QUILS) System

    Behavioral

    The QUILS System is a health services research intervention designed to improve the quality of lung cancer screening programs. The intervention includes QUILS Index Assessment, QUILS Audit and Feedback Report and Presentation, QUILS Resource Portal, site-specific action plans, and formative evaluation activities.

Treatment groups

35,500 Participants
are divided into 1 treatment group
Group A: QUILS System ImplementationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score

The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.

Time frame
Baseline and Month 9

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Timothy Mullett

Lead sponsor

University of Kentucky

Sponsor institution